Gene Symbol | MAGEA2 |
---|---|
Entrez Gene | 4101 |
Alt Symbol | CT1.2, MAGE2, MAGEA2A |
Species | Human |
Gene Type | protein-coding |
Description | melanoma antigen family A2 |
Other Description | MAGE-2 antigen|cancer/testis antigen 1.2|cancer/testis antigen family 1, member 2|melanoma antigen 2|melanoma antigen family A, 2|melanoma-associated antigen 2 |
Swissprots | Q32NC6 A8K328 P43356 |
Accessions | AAA17729 EAW99429 EAW99430 EAW99431 P43356 AK290443 BAF83132 AU100045 BC013098 AAH13098 BC063681 AAH63681 BC108720 AAI08721 BC109188 AAI09189 BC112158 AAI12159 BC112160 AAI12161 BC146449 AAI46450 BG575302 BM781931 BX282627 CA429655 DR158683 XM_011531159 XP_011529461 NM_001282501 NP_001269430 NM_001282502 NP_001269431 NM_001282504 NP_001269433 NM_001282505 NP_001269434 NM_005361 NP_005352 NM_175742 NP_786884 NM_175743 NP_786885 |
Function | Reduces p53/TP53 transactivation function through recruitment of HDAC3 to p53/TP53 transcription sites. Also represses p73/TP73 activity. Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination by TRIM28 potentially in presence of Ubl-conjugating enzyme UBE2H. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T- lymphocytes. Negatively regulates acetylation and sumoylation of PML and represses PML-induced p53/TP53 acetylation and activation. {ECO:0000269|PubMed:16847267, ECO:0000269|PubMed:17942928, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:22117195}. |
Subcellular Location | Nucleus. Nucleus, PML body. |
Tissue Specificity | Expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes. |
Human MAGEA2 full length protein - ab158844 from Abcam
|
||||||||||
Human MAGEA2 full length protein - ab166101 from Abcam
|
||||||||||
MAGEA2 Antibody Blocking Peptide - LS-E8104 from LifeSpan Bioscience
|
||||||||||
MAGEA2 Antibody Blocking Peptide - LS-E21923 from LifeSpan Bioscience
|
||||||||||
Recombinant Human MAGEA2 Protein - H00004101-P01 from Novus Biologicals
|
||||||||||
MAGEA2 Peptide - P1772 from Novus Biologicals
|
||||||||||
MAGEA2-Antibody-N-term-Blocking-Peptide - BP6164a from Abgent, a WuXi AppTec company
|
||||||||||
MAGE-A2-157-166 - SP2473b from Abgent, a WuXi AppTec company
|
||||||||||
MAGE-A2-157-166 - SP2473a from Abgent, a WuXi AppTec company
|
||||||||||
MAGEA2 Blocking Peptide - 33R-4987 from Fitzgerald
|
||||||||||
MAGE-2 - H00004101-P01-10 from Acris Antibodies
|
||||||||||
MAGE-2 - H00004101-P01-25 from Acris Antibodies
|
||||||||||
MAGEA2 fusion protein - Ag6090 from Proteintech Group
|
||||||||||
MAGEA2 fusion protein - Ag5889 from Proteintech Group
|
||||||||||
MAGEA2 fusion protein - ag3141 from Proteintech Group
|
||||||||||
Recombinant Human MAGEA2, His-tagged - MAGEA2-691H from Creative Biomart
|
||||||||||
Recombinant Human Melanoma-associated antigen 2(MAGEA2) - CSB-YP013327HU CSB-EP013327HU CSB-BP013327HU CSB-MP013327HU from Cusabio
|
||||||||||
MAGEA2 Peptide - abx164621 from Abbexa
|
||||||||||
MAGEA2 Peptide, Human - M34GP09083H from Creative Peptides
|
||||||||||
MAGE-2 (157-166) - ta-450 from Creative Peptides
|
||||||||||
MAGE-2 (156-164) - ta-451 from Creative Peptides
|
||||||||||
MAGE-2 (127-136) - ta-452 from Creative Peptides
|
||||||||||
MAGE-2 (212-220) - ta-453 from Creative Peptides
|
||||||||||
Melanoma-associated antigen 2 (MAGEA2), Recombinant Protein - MBS951470 from MyBioSource
|